Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Christopher R, Trevino"'
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 31, Iss , Pp 101156- (2023)
We report partial response (PR) to novel therapy with selumetinib in a patient with neurofibromatosis type 2 (NF2). A 25-year-old male presented with bilateral vestibular schwannomas, spinal cord intramedullary ependymomas, cranial and spinal meningi
Externí odkaz:
https://doaj.org/article/95e7d6ef8f1741fda360afa0a45f1cbd
Autor:
Albert Jang, Ellen B. Jaeger, Elisa M. Ledet, John Xie, Brian E. Lewis, Jodi L. Layton, Oliver Sartor, Pedro C. Barata, Christopher R. Trevino
Publikováno v:
Clinical Genitourinary Cancer. 21:e9-e18
Prostate cancer (PC) rarely metastasizes to the central nervous system (CNS). In this retrospective single-institution study at a tertiary cancer center, we aimed to evaluate the clinical and genetic characteristics of advanced PC patients with CNS m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d16e32e38ef2c0cfaea165c057778dde
https://doi.org/10.1016/j.clgc.2022.10.007
https://doi.org/10.1016/j.clgc.2022.10.007
Autor:
Christopher R Trevino, Nazanin Majd, Gregory N. Fuller, Nicolas R. Metrus, Mark Anderson, Leena Ketonen, Jason T. Huse, Fernando Santos-Pinheiro, Caroline Chung, Marta Penas-Prado
Publikováno v:
Cancer Genetics. :41-45
Astroblastoma is a rare glial neoplasm composed of cells that have broad processes oriented perpendicular to central vessels and often demonstrate vascular sclerosis. The WHO 2016 classification does not specify a grading system for astroblastoma, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::831cfa76a6e86732e0d94660edcccf8d
https://doi.org/10.1016/j.cancergen.2019.01.001
https://doi.org/10.1016/j.cancergen.2019.01.001
Publikováno v:
Neuroimmunology and Neuroinflammation. 2020
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f8b6acf6eb30fa60f58d1f04716aac8
https://doi.org/10.20517/2347-8659.2020.24
https://doi.org/10.20517/2347-8659.2020.24
Autor:
Noah Kolb, Christopher R Trevino, Alissa A. Thomas, Kara K. Landry, Waqar Waheed, Fatemeh Sobhani, Mike Hehir
Publikováno v:
Muscle & Nerve. 58:10-22
Immune checkpoint inhibitor (ICPI) therapy unleashes the body's natural immune system to fight cancer. ICPIs improve overall cancer survival, however, the unbridling of the immune system may induce a variety of immune-related adverse events. Neuromus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2b55d2b23661b779563d26c52935927
https://doi.org/10.1002/mus.26070
https://doi.org/10.1002/mus.26070
Autor:
Carlos Kamiya-Matsuoka, Monica Loghin, Joo Yeon Nam, Rebecca Harrison, Nicholas Metrus, W. K. Alfred Yung, Kathy Hunter, Ahmad Daher, Christopher R Trevino, Marta Penas-Prado, Nazanin Majd, Kristin Alfaro, Barbara O’Brien, John de Groot, Stefania Maraka, Shiao-Pei Weathers
BACKGROUND: Glioblastoma (GBM) is the most common glioma, with an incidence of 3.2 per 100,000 adults, and approximately 12,500 new diagnoses each year in the US. With limited treatment options, there is a constant push to improve patient outcome by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e74da4cf41e16817e762a847d753ea08
https://europepmc.org/articles/PMC6216910/
https://europepmc.org/articles/PMC6216910/
Autor:
Noah A, Kolb, Christopher R, Trevino, Waqar, Waheed, Fatemeh, Sobhani, Kara K, Landry, Alissa A, Thomas, Mike, Hehir
Publikováno v:
Musclenerve.
Immune checkpoint inhibitor (ICPI) therapy unleashes the body's natural immune system to fight cancer. ICPIs improve overall cancer survival, however, the unbridling of the immune system may induce a variety of immune-related adverse events. Neuromus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8c9ff7629066e69fc1b9ba6e6b591e5e
https://pubmed.ncbi.nlm.nih.gov/29342325
https://pubmed.ncbi.nlm.nih.gov/29342325
Autor:
Marta Penas-Prado, Monica Loghin, Ivo W. Tremont-Lukats, Christa Seligman, Sudhakar Tummala, John de Groot, Dibaj Seyedeh, Christopher R Trevino, Barbara O’Brien, Shanta Peinado, Morris D. Groves, Rashmi Krishna Murthy, Shiao-Pei Weathers, Sherise D. Ferguson, Rebecca Harrison, Carlos Kamiya-Matsuoka, Kaylyn D Sinicrope, Pedro C. Barata, Julie Walker
Publikováno v:
Neuro-oncology Advances
BACKGROUND: Leptomeningeal metastasis (LM) is a devastating complication of cancer resulting in progressive neurologic decline. Although intrathecal (IT) methotrexate and cytarabine are commonly used for solid tumor LM, we routinely use IT topotecan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d8c1d73228482c60acf1d797173f1a9
https://doi.org/10.1093/noajnl/vdz014.032
https://doi.org/10.1093/noajnl/vdz014.032
Autor:
Christopher R Trevino, Minjeong Park, Shiao-Pei Weathers, Garret L. Wiliford, Jacob Mandel, Gemma Hallatt, Tim Overeen, Kristin Alfaro-Munoz, John de Groot, Diane D. Liu
Publikováno v:
Journal of Clinical Oncology. 37:2063-2063
2063 Background: Treatment for oligodendroglioma in the molecular era is based on trials that used histologic criteria alone and has evolved over time to include observation and a combination of radiation (RT) and chemotherapy. In particular, treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d51c0e35633cbede1b92945e2cd575ab
https://doi.org/10.1200/jco.2019.37.15_suppl.2063
https://doi.org/10.1200/jco.2019.37.15_suppl.2063
Autor:
Juan Ruiz-Morales, Marta Penas-Prado, Arnold C. Paulino, Jose Perez-Regadera, Christopher R Trevino
Publikováno v:
Neuro-Oncology. 20:vi229-vi229
BACKGROUND: The mechanisms of neurotoxicity from radiation therapy include vascular injury, oxidative damage to neural stem cells and oligodendrocytes, and demyelination, though the pathophysiology is not fully understood. METHODS/PATIENTS: We presen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6343dd1d4252f3faa4339a18882535c5
https://doi.org/10.1093/neuonc/noy148.952
https://doi.org/10.1093/neuonc/noy148.952